FOR IMMEDIATE RELEASE:
Transcranial Magnetic Stimulation is an Essential Treatment
Fresno, CA. July 21, 2020 – Transcranial Magnetic Stimulation (TMS) therapy is a lifesaving medical procedure that has been cleared by the FDA for treatment of Major Depressive Disorder and Obsessive Compulsive Disorder for patients who have not experienced adequate relief from medications and/or psychotherapy. Consistent with the Centers for Disease Control and Prevention guidance, the Clinical TMS Society believes that TMS is an essential medical procedure and should be an available treatment option to patients during the COVID-19 pandemic. When administered using infection control procedures and equipment, TMS therapy can be provided safely and effectively despite the prevalence of COVID-19 infections.
The Clinical TMS Society was established in 2013 and includes Transcranial Magnetic Stimulation (TMS) providers with extensive clinical and research experience from across the United States and the world. The society is dedicated to optimizing clinical practice, awareness, and accessibility of Transcranial Magnetic Stimulation Therapy.
For more information, please reference the CDC Healthcare Facility Guidelines. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-hcf.html
For more information on the Clinical TMS Society please call (845) 392.3238 or visit clinicaltmssociety.org.
Click here to read press release.